Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity

American Journal of Clinical Nutrition

Volumn 94, Issue 5, 2011, Pages 1182-1188

  Paramsothy, Pathmaja ^a,b   Knopp, Robert H ^a,b   Kahn, Steven E ^a,c   Retzlaff, Barbara M ^b   Fish, Brian ^b   Ma, Lina ^d   Ostlund Jr , Richard E ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLESTANOL; CHOLESTEROL; LATHOSTEROL; PHYTOSTEROL; STEROL;

ARTICLE; BODY MASS; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ABSORPTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; OBESITY; RANDOM SAMPLE;

ABSORPTION; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIET; DOUBLE-BLIND METHOD; EGGS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY; PHYTOSTEROLS; STEROLS;

EID: 80054898207     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.006668     Document Type: Article

References (38)

1. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 2005;54:3252-7. (Pubitemid 43334382)
2. Racette SB, Evans EM, Weiss EP, Hagberg JM, Holloszy JO. Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50-95 year olds. Diabetes Care 2006;29:673-8. (Pubitemid 44115372)
3. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB. Body mass, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin EndocrinolMetab 2006;91:2906-12. (Pubitemid 44271734)
4. Bloomgarden ZT. Insulin resistance, dyslipidemia, and cardiovascular disease. Diabetes Care 2007;30:2164-70. (Pubitemid 47219442)
5. Veerkamp MJ, de Graaf J, Stalenhoef AF. Role of insulin resistance in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2005;25:1026-31. (Pubitemid 40627850)
6. Brunzell JD. Clinical practice. Hypertriglyceridemia. N Engl J Med 2007;357:1009-17.
7. Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr 2006;83:1025-31, quiz 205.
8. Knopp RH, Retzlaff B, Fish B, Walden C, Wallick S, Anderson M, Aikawa K, Kahn SE. Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding. Arterioscler Thromb Vasc Biol 2003;23:1437-43. (Pubitemid 36994533)
9. Glickman RM, Green PH. The intestine as a source of apolipoprotein A1. Proc Natl Acad Sci USA 1977;74:2569-73.
10. Ostlund RE Jr, Hsu FF, Bosner MS, Stenson WF, Hachey DL. Quantification of cholesterol tracers by gas chromatography-negative ion chemical ionization mass spectrometry. JMass Spectrom 1996;31:1291-6. (Pubitemid 26392426)
11. Ostlund RE Jr, McGill JB, Zeng CM, Covey DF, Stearns J, Stenson WF, Spilburg CA. Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans. Am J Physiol Endocrinol Metab 2002;282:E911-6. (Pubitemid 34654753)
12. Pihlajamäki J, Gylling H, Miettinen TA, Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 2004;45:507-12. (Pubitemid 38337997)
13. Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990;131:20-31. (Pubitemid 20014696)
14. Scoppola A, Maher VM, Thompson GR, Rendell NB, Taylor GW. Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. J Lipid Res 1991;32:1057-60.
15. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-77. (Pubitemid 9220487)
16. Abbate SL, Fujimoto WY, Brunzell JD, Kahn SE. Effect of heparin on insulin-glucose interactions measured by the minimal model technique: implications for reproducibility using this method. Metabolism 1993; 42:353-7. (Pubitemid 23073354)
17. Katan MB. The response of lipoproteins to dietary fat and cholesterol in lean and obese persons. Curr Atheroscler Rep 2005;7:460-5. (Pubitemid 43033772)
18. Bronsgeest-Schoute DC, Hermus RJ, Dallinga-Thie GM, Hautvast JG. Dependence of the effects of dietary cholesterol and experimental conditions on serum lipids in man. III. The effect on serum cholesterol of removal of eggs from the diet of free-living habitually egg-eating people. Am J Clin Nutr 1979;32:2193-7. (Pubitemid 10206861)
19. Beynen AC, Katan MB. Effect of egg yolk feeding on the concentration and composition of serum lipoproteins in man. Atherosclerosis 1985;54:157-66. (Pubitemid 15140091)
20. Simonen P, Gylling H, Howard AN, Miettinen TA. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 2000;72:82-8. (Pubitemid 30441661)
21. Gylling H, Miettinen TA. Cholesterol absorption: influence of body weight and the role of plant sterols. Curr Atheroscler Rep 2005;7:466-71. (Pubitemid 43033773)
22. Miettinen TA, Gylling H. Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis 2000;153:241-8.
23. Simonen PP, Gylling H, Miettinen TA. Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics. Obes Res 2002;10:328-35. (Pubitemid 135688242)
24. Field FJ, Born E, Mathur SN. Stanol esters decrease plasma cholesterol independently of intestinal ABC sterol transporters and Niemann-Pick C1-like 1 protein gene expression. J Lipid Res 2004;45:2252-9. (Pubitemid 39602972)
25. Calpe-Berdiel L, Rotllan N, Fievet C, Roig R, Blanco-Vaca F, Escola-Gil JC. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. J Lipid Res 2008;49:1904-11.
26. Nomiyama T, Bruemmer D. Liver X receptors as therapeutic targets in metabolism and atherosclerosis. Curr Atheroscler Rep 2008;10:88-95. (Pubitemid 351385604)
27. Palmer RH, Nichols AV, Dell RB, Ramakrishnan R, Lindgren FT, Gong EL, Blum CB, Goodman DS. Lack of relationship in humans of the parameters of body cholesterol metabolism with plasma levels of subfractions of HDL or LDL, or with apoE isoform phenotype. J Lipid Res 1986;27:637-44. (Pubitemid 16052417)
28. van Himbergen TM, Matthan NR, Resteghini NA, Otokozawa S, Ai M, Stein EA, Jones PH, Schaefer EJ. Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers. J Lipid Res 2009;50:730-9.
29. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802-9.
30. McLaughlin T, Abbasi F, Lamendola C, Reaven G. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med 2007;167:642-8. (Pubitemid 46598455)
31. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
32. Matthan NR, Pencina M, LaRocque JM, Jacques PF, D'Agostino RB, Schaefer EJ, Lichtenstein AH. Alterations in cholesterol absorption/ synthesis markers characterize Framingham offspring study participants with CHD. J Lipid Res 2009;50:1927-35.
33. Strandberg TE, Tilvis RS, Pitkala KH, Miettinen TA. Cholesterol and glucose metabolism and recurrent cardiovascular events among the elderly: a prospective study. J Am Coll Cardiol 2006;48:708-14. (Pubitemid 44175730)
34. Goff DC Jr, Shekelle RB, Katan MB, Gotto AM Jr, Stamler J. Does body fatness modify the association between dietary cholesterol and risk of coronary death? Results from the Chicago Western Electric Study. Arterioscler Thromb 1992;12:755-61.
35. Wallace TM, Utzschneider KM, Tong J, Carr DB, Zraika S, Bankson DD, Knopp RH, Kahn SE. Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat. Diabetes Care 2007;30:2673-8. (Pubitemid 47547819)
36. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-72. (Pubitemid 23318125)
37. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002;51: 1005-15. (Pubitemid 34438343)
38. Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH, Kahn SE. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003;52:172-9. (Pubitemid 36042123)